IBDEI151 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18284,1,3,0)
 ;;=3^90621
 ;;^UTILITY(U,$J,358.3,18285,0)
 ;;=90620^^89^919^20^^^^1
 ;;^UTILITY(U,$J,358.3,18285,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18285,1,2,0)
 ;;=2^MENINGOCOCCAL VACCINE,PROTEIN/OUT MEM IM
 ;;^UTILITY(U,$J,358.3,18285,1,3,0)
 ;;=3^90620
 ;;^UTILITY(U,$J,358.3,18286,0)
 ;;=90713^^89^919^23^^^^1
 ;;^UTILITY(U,$J,358.3,18286,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18286,1,2,0)
 ;;=2^POLIOVIRUS,IPV SC/IM
 ;;^UTILITY(U,$J,358.3,18286,1,3,0)
 ;;=3^90713
 ;;^UTILITY(U,$J,358.3,18287,0)
 ;;=90715^^89^919^26^^^^1
 ;;^UTILITY(U,$J,358.3,18287,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18287,1,2,0)
 ;;=2^TDAP VACCINE
 ;;^UTILITY(U,$J,358.3,18287,1,3,0)
 ;;=3^90715
 ;;^UTILITY(U,$J,358.3,18288,0)
 ;;=90691^^89^919^27^^^^1
 ;;^UTILITY(U,$J,358.3,18288,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18288,1,2,0)
 ;;=2^TYPHOID VACCINE IM
 ;;^UTILITY(U,$J,358.3,18288,1,3,0)
 ;;=3^90691
 ;;^UTILITY(U,$J,358.3,18289,0)
 ;;=90716^^89^919^28^^^^1
 ;;^UTILITY(U,$J,358.3,18289,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18289,1,2,0)
 ;;=2^VARIVAX (CHICKEN POX) VACCINE
 ;;^UTILITY(U,$J,358.3,18289,1,3,0)
 ;;=3^90716
 ;;^UTILITY(U,$J,358.3,18290,0)
 ;;=96160^^89^920^4^^^^1
 ;;^UTILITY(U,$J,358.3,18290,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18290,1,2,0)
 ;;=2^HLTH RISK ASSESSMENT,PT FOCUSED
 ;;^UTILITY(U,$J,358.3,18290,1,3,0)
 ;;=3^96160
 ;;^UTILITY(U,$J,358.3,18291,0)
 ;;=96161^^89^920^3^^^^1
 ;;^UTILITY(U,$J,358.3,18291,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18291,1,2,0)
 ;;=2^HLTH RISK ASSESSMENT,CAREGIVR FOCUSED
 ;;^UTILITY(U,$J,358.3,18291,1,3,0)
 ;;=3^96161
 ;;^UTILITY(U,$J,358.3,18292,0)
 ;;=96110^^89^920^2^^^^1
 ;;^UTILITY(U,$J,358.3,18292,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18292,1,2,0)
 ;;=2^DEVELOPMENTAL SCREEN W/ SCORE
 ;;^UTILITY(U,$J,358.3,18292,1,3,0)
 ;;=3^96110
 ;;^UTILITY(U,$J,358.3,18293,0)
 ;;=96127^^89^920^1^^^^1
 ;;^UTILITY(U,$J,358.3,18293,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18293,1,2,0)
 ;;=2^BRIEF EMOTIONAL/BEHAV ASSESSMENT
 ;;^UTILITY(U,$J,358.3,18293,1,3,0)
 ;;=3^96127
 ;;^UTILITY(U,$J,358.3,18294,0)
 ;;=86485^^89^921^1^^^^1
 ;;^UTILITY(U,$J,358.3,18294,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18294,1,2,0)
 ;;=2^CANDIDA
 ;;^UTILITY(U,$J,358.3,18294,1,3,0)
 ;;=3^86485
 ;;^UTILITY(U,$J,358.3,18295,0)
 ;;=86486^^89^921^4^^^^1
 ;;^UTILITY(U,$J,358.3,18295,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18295,1,2,0)
 ;;=2^MUMPS
 ;;^UTILITY(U,$J,358.3,18295,1,3,0)
 ;;=3^86486
 ;;^UTILITY(U,$J,358.3,18296,0)
 ;;=86580^^89^921^5^^^^1
 ;;^UTILITY(U,$J,358.3,18296,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18296,1,2,0)
 ;;=2^TB
 ;;^UTILITY(U,$J,358.3,18296,1,3,0)
 ;;=3^86580
 ;;^UTILITY(U,$J,358.3,18297,0)
 ;;=95024^^89^921^3^^^^1
 ;;^UTILITY(U,$J,358.3,18297,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18297,1,2,0)
 ;;=2^INTRADERMALS (EACH)
 ;;^UTILITY(U,$J,358.3,18297,1,3,0)
 ;;=3^95024
 ;;^UTILITY(U,$J,358.3,18298,0)
 ;;=86510^^89^921^2^^^^1
 ;;^UTILITY(U,$J,358.3,18298,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18298,1,2,0)
 ;;=2^HISTOPLASMOSIS
 ;;^UTILITY(U,$J,358.3,18298,1,3,0)
 ;;=3^86510
 ;;^UTILITY(U,$J,358.3,18299,0)
 ;;=99395^^89^922^1^^^^1
 ;;^UTILITY(U,$J,358.3,18299,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18299,1,2,0)
 ;;=2^PREVENTIVE MED,EST PT 18-39
 ;;^UTILITY(U,$J,358.3,18299,1,3,0)
 ;;=3^99395
